HIF-1α has been shown to control T cell effector function and anti-tumor immune response in hypoxic T cells through its regulatory role on IFN-γ production, whereas HIF-1α deficiency leads to T cell resistance to immune checkpoint blockers [47]. This evidence concerns the gene IFNG and neoplasm.